As of 2026-10-12, the Fair Value of Rain Therapeutics Inc (RAIN) is -3.24 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.67 USD, the upside of Rain Therapeutics Inc is -583.54%.
With the market price of 0.67 USD and our fair value calculation, Rain Therapeutics Inc (RAIN) is not a good investment. Investing in RAIN stocks now will result in a potential loss of 583.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -51.39 | -75.72 | -0.44 | -4.53 | -9.09 | -28.23 |
| YoY growth | -143.79% | -47.34% | 99.42% | -937.45% | -100.53% | -225.94% |
| Market Cap (mil) | 9.79 |
| P/E | |
| Forward P/E |
| EPS | -0.65 |
| Avg earnings growth rate | -225.94% |
| TTM earnings | -9.47 |